zircon: Clinical Trials

2 trials of zircon, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow zircon: new trials by email Literature Review of zircon trials Research Report on zircon

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety & Efficacy of Zirconium Silicate Dosed for 28 Days in Hyperkalemia.
Sodium zirconium cyclosilicate, Placebo - Hyperkalemia
Phase 3CompletedZS Pharma, Inc.2582014-03-312018-12-07
Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia
Zirconium silicate (acute phase), Zirconium silicate (subacute phase), Placebo (acute phase) - Hyperkalemia
Phase 3CompletedZS Pharma, Inc.7542012-11-302018-10-12

Conditions studied

Hyperkalemia (2)

Sponsors

ZS Pharma, Inc. (2)

Countries

Australia (2)  ·  United States (2)  ·  South Africa (1)

Top investigators

Henrik Rasmussen, MD (1)  ·  Henrik Rasmussen, MD, PhD (1)

Results publications

PMID 31791288, PMID 32588430, PMID 25402495, PMID 25415807, PMID 29728199